MacDermid Announces Completion of Share BuyBack with Citigroup Venture Capital

WATERBURY, Conn.--(BUSINESS WIRE)--Sept. 22, 2003--MacDermid, Incorporated (MRD) announced today that it has completed its buyback of shares from Citigroup Venture Capital ("Citigroup") in accordance with its previously announced agreement with Citigroup dated May 7, 2003. Pursuant to the option contained in that agreement, MacDermid, today, purchased the remaining 851,720 shares owned by Citigroup for $25 per share. This transaction completes MacDermid's repurchase of all remaining shares issued to Citigroup in connection with MacDermid's 1999 acquisition of Polyfibron Technologies, Inc.

Daniel Leever, MacDermid's Chairman and Chief Executive Officer stated: "We believe this repurchase represents a prudent use of shareholder funds reflecting our continued strong Owner Earnings performance. At current prices we think this is the best use of our capital. We continue to experience tough end markets, but eagerly await the economic rebound when our earnings leverage will become evident. The repurchase was made with cash on hand, generated from operations. No borrowing on our line of credit was required."

BizVantage – Serious & personalized business, investment and technology intelligence for a serious advantage.
Try the free, no-hassle 6 month trial!

Website: http://www/macdermid.com

MacDermid, Incorporated

NYSE - MRD

CUSIP 554273 10 2

This report and other Corporation reports and statements describe many of the positive factors affecting the Corporation's future business prospects. Investors should also be aware of factors which could have a negative impact on those prospects. These include political, economic or other conditions such as currency exchange rates, inflation rates, recessionary or expansive trends, taxes and regulations and laws affecting the business; competitive products, advertising, promotional and pricing activity; the degree of acceptance of new product introductions in the marketplace; technical difficulties which may arise with new product introductions; and the difficulty of forecasting sales at certain times in certain markets.